688266 泽璟制药
2025/03 -
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产0--0000
固定资产199,387-2.88%205,30198,289109,21499,212
在建工程127,0542.90%123,471135,82786,67327,245
无形资产45,098-9.82%50,01169,27091,030116,291
商誉0--0000
其他非流动资产49,725-0.42%49,93363,48589,63997,257
421,264-1.74%428,715366,871376,556340,005

流动资产
货币资金2,102,867-2.36%2,153,6792,109,641797,0471,136,632
应收账款137,419-4.11%143,304101,14088,98562,371
存货167,491-8.41%182,861110,85298,97851,911
其他流动资产88,784-7.57%96,054198,703306,745155,043
2,496,560-3.08%2,575,8992,520,3361,291,7551,405,956

流动负债
短期借款881,534-7.39%951,862795,165390,793131,809
应付票据18,06776.99%10,208000
应付帐款183,520-1.81%186,895137,735151,721118,191
其他流动负债242,3617.97%224,480202,282186,671130,894
1,325,482-3.49%1,373,4461,135,181729,186380,893
流动资产净值1,171,079-2.61%1,202,4531,385,155562,5691,025,063
资产总额减流动负债1,592,342-2.38%1,631,1691,752,026939,1261,365,068

非流动负债
长期借款59,81334.86%44,351050,0940
应付债券0--0000
其他非流动负债308,800-7.60%334,217107,189101,545111,987
368,612-2.63%378,568107,189151,639111,987

总权益
    实收股本264,7080.00%264,708264,708240,000240,000
    储备项目961,305-2.82%989,1501,368,145519,118956,323
股东权益1,226,013-2.22%1,253,8581,632,853759,1181,196,323
非控股权益(2,283)81.62%(1,257)11,98428,36856,759